The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > Ovalbumin-alum

Ovalbumin-alum

Ovalbumin-alum is a well-established adjuvant system used to enhance immune responses in a variety of research applications.
This complex combines the model antigen ovalbumin with aluminum-based adjuvants, such as aluminum hydroxide or aluminum phosphate, to potentiate antigen-specific antibody production and cell-mediated immunity.
Ovalbumin-alum protocols are widely utilized across immunology, vaccinology, and preclinical studies to evaluate humoral and cellular immune responses.
Optimizing these protocols can be challening, but the AI-driven PubCompare.ai platform can help researches identify the best methodolgies and products from the literature, preprints, and patents to improve reproducibility and accuracy in their ovalbumin-alum experiments.

Most cited protocols related to «Ovalbumin-alum»

Acridine orange, ATP, bafilomycin A1, cytochalasin D, LPS, PMA, poly(deoxyadenylic-thymidylic) acid sodium salt (dAdT), sucrose and zymosan were purchased from Sigma-Aldrich (St. Louis, MO). CA-074-Me and PEG 1000 were purchased from Calbiochem (Gibbstown, NJ). DQ-ovalbumin, A647-conjugated dextran, A647-conjugated choleratoxin B, lysosensor green and Hoechst stain were obtained from Molecular Probes, Invitrogen (Carlsbad, CA). Alum (Imject Alum Adjuvant, mixture of aluminum hydroxide and magnesium hydroxide) was purchased from Pierce (Rockford, IL). Leu-Leu-OMe·HCl was purchased from Chem-Impex International (Wood Dale, IL). Uricase (Elitek™) was purchased from Sanofi-Aventis (Bridgewater, NJ).
Silica crystals (MIN-U-SIL-15) were kindly provided by U.S. Silica Company (Berkeley Springs, WV). Throughout the study, a polydispersed preparation of silica crystals of up to 15 µm were used. MSU crystals were prepared as previously described37 (link).
Publication 2008
Acridine Orange alum, potassium bafilomycin A1 CA 074 Choleragenoid Cytochalasin D Dextran Elitek Hydroxide, Aluminum leucyl-leucine-methyl ester Magnesium Hydroxide Molecular Probes Natural Springs Ovalbumin Poly A polyethylene glycol 1000 Silicon Dioxide Sodium Sodium Chloride Stains Sucrose Thymidine Monophosphate Urate Oxidase Zymosan
A transgenic mouse (αSMA-hrGFP) expressing hrGFP under the control of the rat α-smooth muscle actin (αSMA) gene promoter was generated [9] (link). αSMA-hrGFP mice selectively express hrGFP in smooth muscle cell populations in vivo. C57/Bl6 and NG2-DsRed transgenic mice that expresses the red fluorescent protein (DsRed.T1) under the control of the mouse NG2 (Cspg4) promoter [10] (link) were obtained from Jackson Laboratories (Bar Harbor, MN). The αSMA-hrGFP;NG2-DsRed mouse was generated by crossing αSMA-hrGFP with NG2-DsRed mice. To induce acute allergic airway inflammation, adult mice received two intraperitoneal (i.p.) injections of 50 µg ovalbumin (OVA) in Imject Alum (Thermo Scientific, Waltham, MA) on days 0 and 7, followed by 20-minute nebulizations with a 2% OVA solution on days 14, 15, 16, 17, and 18. Control mice were sensitized with PBS followed by 5 nebulizations with OVA solution. Mice were analyzed on day 19. Description of this model is included in the supplementary material section. All animal studies were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the NIH. The protocol was approved by the Boston University IACUC Committee (protocol number: AN-15112).
Full text: Click here
Publication 2013
Actins Adult alum, potassium Animals Animals, Laboratory CSPG4 protein, human Genes Inflammation Institutional Animal Care and Use Committees Mice, Laboratory Mice, Transgenic Myocytes, Smooth Muscle Ovalbumin Population Group red fluorescent protein smooth muscle actin, rat Smooth Muscles
All behavioral tests were performed with an experimenter blind to genotype. The mice were 2 to 3 month-old males (20–30 g) that had been backcrossed to C57Bl/6 mice for at least six generations. All experiments were performed under the protocol approved by the Animal Care and Use Committee of Johns Hopkins University School of Medicine. 5 weeks old MrgprA3GFP-Cre; ROSA26DTR mice and ROSA26DTR littermates were injected with diphtheria toxin (i.p., 40ug/kg, EMD Biosciences) twice separated by 72 hrs. Behavioral experiments were performed three weeks after the first toxin injection. The day before the behavioral tests, all animals were acclimated for at least 30 min to their testing environment. We housed 4–5 mice in each cage in the vivarium with 12 hr light/dark cycle and all the behavioral tests were performed in the morning.
Back injections and cheek injections of chemicals were performed as previously described 35 (link). Briefly, pruritic compounds were subcutaneously injected into the nape of the neck for back injection and the right cheek of the animal for the cheek injection after acclimatization. Behavioral responses were video recorded for 30 min. The video recording was subsequently played back in slow-motion and the number of bouts of scratching with the hindpaw and also, for the cheek, wiping with the forepaw, each directed toward the injection site, were counted.
In the dry skin model, the rostal back of the mice were treated twice daily with cutaneous application of acetone/ether (1:1) mixture followed by water. After a 6-day treatment, the mice showed robust spontaneous scratching and the treated skin area exhibited decreased stratum corneum hydration and increased trans-epidermal water loss, which mimic the symptoms of dry skin in patients29 (link), 31 (link). In an allergy model of itch, 50 µg ovabumin dissolved in PBS was administered intraperitoneally together with 2 mg of Inject Alum twice separated by 10 days. One week after the second sensitization, 50 µg ovalbumin dissolved in saline was administered in the same manner as other pruritogens and scratching behavior was quantified.
For the hot plate test, a clear plexiglass cylinder was placed on the plate and the mice were placed inside the cylinder. The onset of brisk hindpaw lifts and/or flicking/licking of the hindpaw was assessed at different temperatures.
For the cold plate test, a ceramic plate on a bed of ice was cooled in a −20°C freezer. During the test, the plate was allowed to warm to 0°C as measured by two independent temperature probes. The onset of brisk hindpaw lifts and/or flicking/licking of the hindpaw was assessed.
For the tail immersion test, mice were gently restrained in a 50 ml conical tube into which the mice voluntarily entered. The protruding one third of the tail was then dipped into a water bath of varying temperatures. The latency to respond to the heat stimulus with vigorous flexion of the tail was measured.
For the Hargreaves test, mice were placed under a transparent plastic box (4.5 × 5 × 10 cm) on a glass floor. The infrared source was placed under the glass floor and the infrared light was delivered to the hindpaw. The latency for the animal to withdraw its hindpaw was measured.
For the Von Frey filament test, mice were placed under a transparent plastic box (4.5 × 5 ×10 cm) on a metal mesh. Von Frey filaments, each delivering a different bending force, were applied to the hind paw using the up-down method and the threshold force corresponding to 50% withdrawal determined.
For the chemically-induced pain test, an intraplantar injection was used to administer a total volume of 6 μl of capsaicin (1 mg in 10 ml saline/7% Tween-80), or formalin (2% formalin in saline). The time mice spent licking and flinching was measured for 15 minutes after capsaicin injection and for 1hr after formalin injection.
For the Rotarod test, each mouse was trained for 5 minutes at a constant speed of 4 rpm on the rotarod (Rotamex, Columbus Instruments). The first trial started at least 1 hour after training. Every day, each mouse received 3 trials, separated by 30 minutes, at speeds accelerating from 4 to 40rpm (with a 4 rpm increase every 30 s). Each mouse was tested for 3 consecutive days. The trial was finished when the mouse fell off the rotarod. The latency to falling off the rotarod was recorded and used in subsequent analyses.
Publication 2012
Tbxa2r−/− mice were obtained from Dr. Thomas Coffman (Duke University, Durham, NC) (18 (link)). P2ry12−/− mice were from Portola Pharmaceuticals (San Francisco, CA) (19 (link)). Cysltr1−/−, Cysltr2−/−, and Gpr99−/− mice were generated in our institution (10 (link),20 (link),21 (link)). Mice were sensitized I.P. on days 0 and 7 with Alum-precipitated chicken egg ovalbumin (OVA, Sigma, 10 μg) and challenged by inhalation of 0.1% OVA with or without intranasal cys-LTs as described (22 (link)). Platelets were depleted by an I.P. injection of an anti-CD41 antibody (clone MWReg30, Biolegend) or an isotype control (23 ).
Publication 2013
Blood Platelets Chickens Clone Cells CYSLTR2 protein, human Immunoglobulin Isotypes Inhalation Mus ovalbumin-alum Passive Immunization Pharmaceutical Preparations
Airway inflammation and remodelling was induced in female Balb/c mice sensitized with ovalbumin (OVA) in alum as previously described [18 (link)]. Prolonged inflammation was induced by subsequent exposure to aerosolized OVA (5%) three times a week for 20 min until groups of mice were sacrificed on days 35 and 55. A therapeutic regimen was instigated by initiating Budesonide treatment (Pulmicort, AstraZeneca, UK, 1mg/kg intra peritonial (i.p.)) on day 26, after the establishment of considerable lung eosinophilia and airway hyper-reactivity. Control mice received the same dose of vehicle (phosphate-buffered saline (PBS)). Mice were sacrificed on day 35 (after four doses of Budesonide and OVA challenges) or on day 55 (after 13 Budesonide doses and OVA challenges). For comparison in some figures, we have included two more groups of mice: mice which have been sensitized and challenged through the airways with OVA but sacrificed on day 24 of the acute phase of allergic inflammation (day 24 group) and mice which have been given a sham immunization with alum alone (alum group) and challenged with OVA before sacrifice on day 55. The challenge and treatment protocol is shown in Fig. 1.
Publication 2005
alum, potassium Budesonide Females Inflammation Mice, Inbred BALB C Mus Ovalbumin Phosphates Pulmicort Pulmonary Eosinophilia Saline Solution Treatment Protocols Vaccination

Most recents protocols related to «Ovalbumin-alum»

Not available on PMC !
On the first day, the rats were sensitized by injecting 0.6 ml of (0.9% NaCl) normal saline comprising alum (4 mg) and ovalbumin (2 mg) into four-foot pads. They were boosted five days later with a subcutaneous injection of 1 ml of normal saline comprising ovalbumin (2 mg) at ten locations on the back. Later, from day 8 to 15 d, local sensitization was performed by instilling ovalbumin in normal saline (30 µl) per site into bilateral eyes with a micropipette, and the symptoms were assessed.
Publication 2024
Following the established procedures [17 (link)], mice were treated with the ovalbumin (OVA)-aluminum hydroxide (alum) protocol as illustrated in Fig. S4 in the supplemental materials. The animal experimental protocols were approved by the Animal Ethics Committee of Shenzhen University (Approve#2022-008).
Full text: Click here
Publication 2024
Mice were injected intraperitoneally (i.p.) twice, 14 days apart, with 100μg Ovalbumin (OVA, Sigma-Aldrich, #A5503) in 200μl containing 12.5% Imject alum adjuvant (ThermoFisher, #77161). Ten days after the last injection mice were anaesthetized with isoflurane and challenged i.n. with 30μg OVA in 30μL injection grade sterile saline. Mice were infected with SCV2 5 – 6 days after i.n. OVA challenge.
Full text: Click here
Publication Preprint 2024
Not available on PMC !
Bakuchicin (BKC), dexamethasone (DEX), AGK2, ovalbumin (OVA), and LPS (Escherichia coli, 055:B5) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The alum adjuvant was purchased from Thermo Scienti c (Waltham, MA, USA). The enzyme-linked immunosorbent assay kits for mouse TNF-α, IL-1β, IL-4, IL-5, IL-6, IgE, IgG1, and IgG2a were purchased from BD Biosciences (San Diego, CA, USA).
Publication 2024
As a measure of the reduction of experimental animal use, the animals reported here served as control groups in other experiments and were intranasally (i.n.) treated with 25 µl PBS once before the first OVA sensitization (day -14). From two weeks after control treatment with PBS, mice were sensitized i.p. with 10 µg ovalbumin (OVA, grade V, Sigma-Aldrich, St. Louis, MO, USA) in PBS containing 1 mg aluminium hydroxide (alum; Imject™ Alum Adjuvant, Thermo Fisher) in three weekly intervals (day 0, 7 and 14). Control mice were mock-sensitized i.p. with alum only on days 0, 7 and 14. One week after the last sensitization, on three consecutive days (day 21, 22 and 23) all mice were intranasally (i.n.) challenged with 100 µg OVA (grade III, Sigma-Aldrich) in 30 µL PBS under light isoflurane anesthesia. Forty-eight hours after the last challenge (day 25), all mice were sacrificed and bronchoalveolar lavage (BAL), serum and lungs were harvested for further analyses (for timeline see Figure 1A).
Full text: Click here
Publication 2024

Top products related to «Ovalbumin-alum»

Sourced in United States, Germany, United Kingdom, China, Sao Tome and Principe, France, Japan, Italy, Switzerland, Denmark, Macao, Canada, Australia, Brazil
The OVA is a laboratory equipment product designed for the detection and analysis of eggs or ova. It provides a reliable and standardized method for sample preparation and observation. The core function of the OVA is to facilitate the identification and quantification of eggs or ova in various samples.
Sourced in United States, Japan, United Kingdom, Germany, France
Imject Alum is a laboratory product used as an adjuvant. It is designed to enhance the immune response to administered antigens.
Sourced in United States, Japan
Imject Alum Adjuvant is a laboratory reagent used to enhance the immune response to antigens in research applications. It functions as an adjuvant, a substance that increases the effectiveness of vaccines or other immunological products. The core purpose of Imject Alum Adjuvant is to potentiate the immune response to the target antigen being studied.
Sourced in United States, Germany, Spain, Macao
The OVA (grade V) is a lab equipment product from Merck Group. It is designed for laboratory use and serves a core function in the research and analysis processes. Due to the technical nature of this product, a detailed description while maintaining an unbiased and factual approach cannot be provided. Therefore, a more comprehensive description is not available.
Sourced in United States
Alum adjuvant is a mineral-based adjuvant used in the formulation of vaccines. It is composed of aluminum salts, specifically aluminum hydroxide or aluminum phosphate, which enhance the immune response to the vaccine antigen. Alum adjuvant is widely used in the pharmaceutical industry to improve the efficacy and potency of various vaccine products.
Sourced in New Zealand, United States, United Kingdom
NP-OVA is a laboratory instrument used for the analysis and detection of nucleic acids. It is designed to perform efficient and reliable quantification of nucleic acid samples. The core function of NP-OVA is to provide accurate and reproducible results for researchers and scientists in various fields of study.
Sourced in United States
Aluminum hydroxide (alum) is a laboratory chemical compound with the molecular formula Al(OH)3. It is a white, crystalline solid that is commonly used as a coagulant and flocculant in water treatment processes. Alum has the core function of facilitating the removal of suspended particles and impurities from water or other aqueous solutions.
Sourced in United States, Germany, China, Sao Tome and Principe, United Kingdom, Japan, Italy, Canada, Hungary, Macao
Pentobarbital sodium is a laboratory chemical compound. It is a barbiturate drug that acts as a central nervous system depressant. Pentobarbital sodium is commonly used in research and scientific applications.
Sourced in United States, Germany
A5503 is a laboratory equipment product manufactured by Merck Group. It is designed for general laboratory applications. The core function of this product is to provide a reliable and consistent tool for researchers and scientists in their day-to-day laboratory activities.
Sourced in United States, France
The OVA is a lab equipment product designed for the extraction and purification of ovalbumin, a protein commonly found in egg whites. It provides a reliable and efficient method for researchers to isolate this protein for various scientific applications.

More about "Ovalbumin-alum"